CLINICAL PHARMACOKINETICS OF 6-HOUR INFUSION OF HIGH-DOSE METHOTREXATE - PRELIMINARY TRIAL OF MONITORING HIGH INFUSION DOSES

被引:7
作者
LUYCKX, M
CAZIN, JL
BRUNET, C
GOSSELIN, P
DEMAILLE, MC
机构
[1] FAC PHARM LILLE,PHARMACOL LAB,3 RUE PROF LAGUESSE,F-59045 LILLE,FRANCE
[2] CTR OSCAR LAMBRET,SERV ONCOL PEDIAT,F-59020 LILLE,FRANCE
关键词
D O I
10.1007/BF00544367
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:457 / 462
页数:6
相关论文
共 25 条
[1]  
BLENDER RA, 1978, DRUGS, V16, P46
[2]  
BLEYER WA, 1978, CANCER-AM CANCER SOC, V41, P36, DOI 10.1002/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO
[3]  
2-I
[4]   RADIOIMMUNOASSAYS OF 7-HYDROXYMETHOTREXATE AND METHOTREXATE [J].
BORE, P ;
RAHMANI, R ;
CANO, JP ;
JUST, S ;
BARBET, J .
CLINICA CHIMICA ACTA, 1984, 141 (2-3) :135-149
[5]   PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE TREATMENT IN CHILDREN [J].
BRATLID, D ;
MOE, PJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (02) :143-147
[6]  
CAZIN JL, 1984, TRENDS PHARMACOL SCI, V5, P411
[7]  
COHEN HJ, 1978, CANCER CHEMOTH PHARM, V1, P61
[8]  
CROM WR, 1981, INDIVIDUALIZING DRUG
[9]  
EVANS WE, 1979, CANCER CHEMOTH PHARM, V3, P161
[10]   HIGH-DOSE METHOTREXATE - A CLINICAL AND PHARMACOKINETIC EVALUATION - TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK USING A PROSPECTIVE MATHEMATICAL-MODEL AND PHARMACOKINETIC SURVEILLANCE [J].
FAVRE, R ;
MONJANEL, S ;
ALFONSI, M ;
PRADOURA, JP ;
BAGARRYLIEGEY, D ;
CLEMENT, S ;
IMBERT, AM ;
LENA, N ;
DISTRIA, JC ;
CANO, JP ;
CARCASSONNE, Y .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :156-160